Decreasing cardiovascular morbidity: how to improve adherence to the treatment in the translational era
Cardiovascular diseases are the main drivers of the morbidity and mortality in Russian Federation. We briefly discussed the poor adherence of the patients and outlined the solutions of this problem.
Main Author: | I. V. Zhirov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2020-10-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/46855/32008 |
Similar Items
-
LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS?
by: I. V. Zhirov
Published: (2016-01-01) -
COMBINED ACETYLSALICYLIC ACID TABLETS TECHNOLOGY
by: A. V. Simonyan, et al.
Published: (2019-01-01) -
Aspirin for thromboembolic complication prevention in cardiovascular disease: dose optimization and adverse effect minimization
by: A. N. Britov
Published: (2006-12-01) -
An investigation of formulation factors and processing parameters for the powder-coating of tablets
by: Sauer, Dorothea, 1979-
Published: (2008) -
1) Pharmacokinetic modeling and simulations of gastrointestinal transit effects on drug pharmacokinetics from enteric-coated pellet formulations and their applications ; 2) development of crushable enteric-coated formulations ; 3) development of leaky enteric-coated pellets formulations
by: Watanalumlerd, Prapoch
Published: (2012)